Emergency MedicineAndexanet reverses anticoagulant effects of factor Xa inhibitorsNovember 16, 2015CardiologyDVT & Pulmonary Embolism
Emergency MedicineCHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacyNovember 5, 2015PulmonologyCardiologyDVT & Pulmonary Embolism
Emergency MedicineIdarucizumab approved as first agent to reverse a novel oral anticoagulantOctober 16, 2015CardiologyHematologyDVT & Pulmonary Embolism
Emergency MedicineHome VTE treatment with rivaroxaban safe and effectiveJuly 22, 2015CardiologyPulmonologyHematologyDVT & Pulmonary Embolism
Emergency MedicineHigh VTE recurrence risk persists for at least 3 yearsJuly 9, 2015PulmonologyCardiologyHematologyDVT & Pulmonary Embolism
Emergency MedicineExtended warfarin delays return of unprovoked pulmonary embolismJuly 7, 2015PulmonologyCardiologyHematologyDVT & Pulmonary Embolism
Emergency MedicineIdarucizumab reverses dabigatran’s anticoagulant effectsJune 24, 2015DVT & Pulmonary EmbolismCardiologyTraumaHematology
Emergency MedicineFDA approves cangrelor, an intravenous antiplatelet drugJune 24, 2015CardiologyDVT & Pulmonary Embolism
Emergency MedicineThink ESUS, not cryptogenic strokeMay 31, 2015Mental HealthNeurologyDVT & Pulmonary Embolism
Emergency MedicineFrozen RBCs match fresh in safety, effectivenessMay 12, 2015TraumaDVT & Pulmonary Embolism
Emergency MedicineSimplified PESI identified low-risk pulmonary embolismApril 23, 2015PulmonologyDVT & Pulmonary Embolism
Emergency MedicineLow-risk PE patients can be treated as outpatientsApril 20, 2015PulmonologyDVT & Pulmonary Embolism
Emergency MedicineFondaparinux safe for VTE prophylaxis in ischemic strokeApril 19, 2015Mental HealthCardiologyNeurologyDVT & Pulmonary Embolism
Emergency MedicineExtended anticoagulant therapy reduced risk of VTE recurrenceMarch 25, 2015HematologyDVT & Pulmonary Embolism
